Christopher Patusky, Director, on April 17, 2026, sold 1,000 shares in United Therapeutics (UTHR) for $578,880. Following the Form 4 filing with the SEC, Patusky has control over a total of 2,590 common shares of the company, with 1,490 shares held directly and 1,100 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1082554/000123142726000001/xslF345X05/primarydocument.xml
Sytse Sijbrandij, Director, on April 15, 2026, sold 116,200 shares in Gitlab (GTLB) for $2,413,474.SEC Filing:https://www.sec.gov/Archives/edgar/data/1653482/000165348226000053/xslF345X05/wk-form4_1776375056.xml
Catherine Corrigan, Director, President & CEO, on March 16, 2026, sold 7,821 shares in Exponent (EXPO) for $528,639. Following the Form 4 filing with the SEC, Corrigan has control over a total of 104,359 common shares of the company, with 104,359 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/851520/000085152026000057/xslF345X05/edgardoc.xml
Dwight A Merriman, Director, on April 14, 2026, sold 12,000 shares in Mongodb (MDB) for $2,904,414. Following the Form 4 filing with the SEC, Merriman has control over a total of 1,561,474 common shares of the company, with 1,005,316 shares held directly and 556,158 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1441816/000162828026025556/xslF345X05/wk-form4_1776373965.xml